HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Myoclonic astatic epilepsy and the role of the ketogenic diet.

Abstract
The ketogenic diet remains one of the most effective treatments for medically refractory childhood epilepsy. In spite of the long history of its use, relatively little is known about the mechanism of action. The diet's efficacy in a wide range of epilepsy syndromes suggests that it may have multiple mechanisms of action, each of which may be more relevant to a specific disease state. Further research is necessary to define the mechanism of action, which may, in turn, lead to easier means to provide the therapeutic benefit.
AuthorsJessica E Mulligan, David E Mandelbaum (Affiliation: Children's Neurodevelopment Center, Rhode Island Hospital/Hasbro Children's Hospital, USA. jmulligan at lifespan.org)
JournalMedicine and health, Rhode Island (Med Health R I) Vol. 94 Issue 5 Pg. 127-30 (May 2011) ISSN: 1086-5462 [Print] United States
PMID21710920 (Publication Type: Case Reports, Journal Article, Review)
Topics
  • Child, Preschool
  • Epilepsies, Myoclonic (diet therapy)
  • Humans
  • Ketogenic Diet (adverse effects, methods)
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD